Dr. Rayaz Ahmed is a highly experienced Senior Director in the field of Cancer Care/Oncology, specializing in Bone Marrow Transplant, Hematology Oncology, and Hematology. With over 20 years of experience, Dr. Ahmed is one of the leading oncologists in India. He is recognized for his expertise in treating complex cases of hematologic cancers, including leukemia, lymphoma, and multiple myeloma. His contributions to the field of bone marrow transplant are particularly noteworthy, as he has performed numerous successful transplants, significantly improving patient outcomes.

Dr. Ahmed completed his MBBS, MD (Medicine), and DM (Hematology), and has been instrumental in advancing treatments in both hematology and oncology. Throughout his career, he has also contributed to several research projects and has been a part of numerous national and international conferences, continuously evolving his treatment protocols in line with the latest global advancements.

Currently, Dr. Ahmed serves as a Senior Director at Max Healthcare, where he leads a team focused on cutting-edge treatments in hematology and oncology. His approach emphasizes personalized care, ensuring the best possible outcomes for his patients. He is a member of several prestigious medical societies and has received numerous awards for his contributions to cancer care and bone marrow transplantation. His commitment to patient-centric care, along with his strong academic background, has made him a trusted name in the medical community.

Experience Overview

Here’s the description in point-wise format for Dr. Rayaz Ahmed:

• Current Role: Senior Director at Max Healthcare, Delhi, India
• Total Experience: Over 17 years
• Bone Marrow Transplants: More than 1000 transplants performed
• Previous Roles:
  • Senior Consultant, Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
  • Associate Professor, Department of Hematology, Christian Medical College (CMC), Vellore, Tamil Nadu
• Specialization:
  • Hematology
  • Hematology Oncology
  • Bone Marrow Transplant
• Qualifications:
  • MBBS, Pt. Ravi Shanker University, Raipur, C.G., India (1999)
  • MD, Shivaji University Kolhapur, Maharashtra (2003)
  • DM, Christian Medical College & Hospital, Vellore, Tamil Nadu (2010)

Professional Memberships

Here’s a detailed, point-wise breakdown:

Professional Memberships:

• Member of leading medical societies related to hematology and oncology.

Awards:

• University Gold Medal in MD Pathology (2003), Shivaji University, Kolhapur, Maharashtra.
• Successfully conducted various types of stem cell transplants:
  • Autologous Stem Cell Transplant
  • Allogeneic Stem Cell Transplant (Matched Sibling Donor, Matched Unrelated Donor, Haplo Identical)

Specialty Interests:

• Stem Cell Transplants:
  • Autologous Stem Cell Transplant
  • Allogeneic Stem Cell Transplant (MSD, MUD, Haplo)
• Treatment of blood disorders such as:
  • Aplastic Anemia
  • Thalassemia and Sickle Cell Anemia
• Leukemia (AML/ALL/CML/CLL)
• Lymphoma (Hodgkin and Non-Hodgkin)
• Multiple Myeloma

Research Papers & Publications:

• Chronic Immune Thrombocytopenia (ITP): Outcomes following splenectomy for chronic and persistent ITP.
• Chronic Myeloid Leukemia (CML): Factors influencing adherence to imatinib in Indian CML patients.
• Hairy Cell Leukemia: Study on BRAF mutations in hairy cell leukemia.
• Aplastic Anemia: Use of a fludarabine-based conditioning regimen for severe aplastic anemia.
• Hemoglobin Disorders: Molecular characterization of novel mutations causing hypochromic microcytic anemia.
• Leukemia Treatment: Outcomes with low-cost protocols for T-cell acute lymphoblastic leukemia (ALL) in India.
• Thalassemia Treatment: Improved outcomes with HLA-matched related allogeneic stem cell transplant using a treosulfan-based conditioning regimen.
• CML Diagnosis: FISH patterns of BCR/ABL1 fusion in CML.
• Wiskott-Aldrich Syndrome: Molecular basis in Indian patients.
• AML Treatment: Influence of carbonyl reductase 1 expression on daunorubicin metabolism in acute myeloid leukemia.

This compilation showcases the breadth of Dr. Rayaz Ahmed’s expertise and contributions to hematology, oncology, and stem cell transplantation.

Languages Spoken

Here is the information in a point-wise format:

• Languages Spoken:
  • English: Proficient and used for medical communication.
  • Hindi: Fluent, allowing effective communication with a wide range of patients, especially in India.
• Communication Benefits:
  • Ability to explain complex medical procedures and conditions clearly.
  • Connects effectively with a diverse patient population across India.
  • Bilingual skills enhance patient care and ensure better understanding of treatment plans.